Archive for the ‘Arizona Foreign Exchange Companies’ Category
September 17th, 2007 | 
Author: PHOENIX–(BUSINESS WIRE)–Buyers came from as far away as Australia, Qatar and Mexico to attend the US$28 million unreserved industrial auction conducted by Ritchie Bros. Auctioneers (NYSE: RBA) (TSX: RBA) in Phoenix, Arizona, last week. Almost 1,700 construction, transportation and other industrial equipment items were sold on behalf of more than 250 consignors at the public auction, attracting over 1,600 registered bidders from 27 countries, including 46 U.S. states and nine Canadian provinces. Buyers from outside the state of Arizona purchased almost half of the equipment in the auction, representing US$19 million in gross auction proceeds (almost 70 per Read the rest of this entry »
Posted in 
Sopra Group, for Axway finalised yesterday the acquisition of Atos Origin’s B2B activities in Germany. This operation solidifies Axway’s leadership in the B2B platform domain and significantly reinforces its presence in Germany, the largest European market.
SCOTTSDALE, Ariz. & PARIS–(BUSINESS WIRE)–Regulatory News:
Axway, a wholly-owned subsidiary of Sopra Group (Paris:SOP), has acquired 100% of the B2B software activity of Atos Origin in Germany. The transaction was paid in cash.
The two entities have multiple complementarities, such as geographic positioning and expertise in client business domains, which help place Axway among the leading vendors in Germany. Additionally, this acquisition solidifies Axway’s leadership in the EDI and B2B platform markets in Europe and consolidates its positioning in the Automotive sector. Read the rest of this entry »
Chief of Scientific Development to Give Lecture on Patentability in Biotechnology
SCOTTSDALE, AZ — (MARKET WIRE) — Medistem Laboratories’ (OTCBB: MDSM) (FRANKFURT: S2U) Thomas Ichim, Chief of Scientific Development, was invited to talk at the 4th Annual Regenerative Medicine Organization Conference in Las Vegas on the subject of “Intellectual Property in Biotechnology.” Read the rest of this entry »
TUCSON, Ariz.–(BUSINESS WIRE)–Liberty Star Gold Corp (the “Companyâ€), (OTCBB:LBTS) is pleased to announce that the Elle Joint Venture with XState Resources Limited (ASX:XST) (previously OCR Minerals) has engaged a specialized air rotary drill. This drill is designed so that a true vertical hole can be drilled through the cobbles and boulders of the three targeted uranium bearing collapse breccia pipes without significant deviation. The drill will penetrate to a depth of at least 1,500 feet in each of the three pipes comprising the initial part of the joint venture. Drilling is expected to start on February 15, 2007. It is expected that drilling will take about a month to two months to complete. Read the rest of this entry »
VANCOUVER, BRITISH COLUMBIA — (MARKET WIRE) — Entree Gold Inc. (TSX: ETG)(AMEX: EGI)(FWB: EKA) (”Entree” or the “Company”) reports that results from the geophysical survey completed on its Sol Dos Property, Arizona have been received and evaluated. Drill targets have been identified and documentation has been submitted to the Bureau of Land Management (”BLM”) for permitting of the proposed follow-up exploration program. A drilling contract has been signed with Boart Longyear for 6,550 feet (2,000 m) of diamond drilling. The drilling program will commence shortly after receipt of permit approval from the BLM, which is estimated to take 2 – 4 weeks. Read the rest of this entry »
Kim Loughead, Second Executive from McKesson, Joins Axway to Drive Business Strategy
SCOTTSDALE, Ariz. & PARIS–(BUSINESS WIRE)–Axway, Inc. today announced that Kim Loughead has joined Axway’s healthcare executive team from McKesson Corporation. Loughead, the second executive to join Axway from McKesson, will take on the role of director of business development. Paul Fowler, formerly McKesson’s vice president of e-commerce and emerging technologies, also joined the company from McKesson in Nov. 2006 to lead its global healthcare initiatives as vice president of healthcare strategy. With Loughead’s experience in Read the rest of this entry »
Novel Use of Existing Drug Outlined in Journal of Translational Medicine
SCOTTSDALE, AZ — (MARKET WIRE) — January 30, 2007 — Medistem Laboratories, Inc. (OTCBB: MDSM) (FRANKFURT: S2U) announced the publication of a peer reviewed paper proposing a novel approach for treatment of chronic myeloid leukemia using a clinically approved drug already on the market for unrelated symptoms. Chronic myeloid leukemia is a disease of the blood forming bone marrow stem cell. The disease affects 1 to 2 people per 100,000 and accounts for 7 – 20% cases of leukemia. Read the rest of this entry »
Product Aims to Induce Formation of New Blood Vessels, Providing New Method of Treatment for Cardiovascular, Critical Limb Ischemia, and Other Diseases
SCOTTSDALE, AZ — (MARKET WIRE) — Medistem Laboratories, Inc. (OTCBB: MDSM) (FRANKFURT: S2U), announced today it has filed a patent application covering its Angiostemâ„¢ platform, a technology with potential to benefit cardiac and limb ischemic diseases. Angiostemâ„¢ is planned to be the company’s first pipeline product intended for U.S. commercialization. Read the rest of this entry »
VANCOUVER, BRITISH COLUMBIA — (MARKET WIRE) — December 08, 2006 — Wildcat Silver Corporation (CNQ: WILD) (the “Company”) is pleased to announce that the Plan of Arrangement (the “Arrangement”) pursuant to which the Company will spin out its wholly owned subsidiary, Ventana Gold Corp. (”Ventana”), to the shareholders of the Company, will be effective on December 14, 2006. All holders of Company shares as of the December 14, 2006 record date will be entitled to receive Ventana shares on the basis of one common share of Ventana for each Read the rest of this entry »
TORONTO, ONTARIO — (MARKET WIRE) — December 07, 2006 — Denison Mines Corp. (”Denison” or the “Company”)(TSX: IUC)(TSX: DEN) is pleased to announce that the Company will commence trading as Denison Mines Corp. (”New Denison”) on the Toronto Stock Exchange under the symbol “DML” effective today, at the market opening on December 7, 2006. The new CUSIP number of the common shares will be 248356107 and the ISIN number will be CA 2483561072. Read the rest of this entry »
